文献速递神经肿瘤神经重症

术后和肽素对预测术后精氨酸加压素缺乏症的效用

Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency.
PubMed 文献 · J Neurosurg · 2023-11-10

本研究纳入2020年2月至2022年4月因垂体病变手术且无术前精氨酸加压素缺乏症(AVD)的成人,术后早期(拔管后6小时内)和术后第1天(POD1,拔管后10-30小时)采血测和肽素。192例中22例(11.5%)发生AVD,早期和肽素最佳切点<8.5 pmol/L(敏感度0.70,特异度0.80),POD1最佳切点<4.3 pmol/L(敏感度0.82,特异度0.63);早期切点22.9 pmol/L时敏感度95%、阴性预测值99%。

要点

  • 术后早期和肽素<8.5 pmol/L预测AVD,敏感度0.70、特异度0.80、阴性预测值0.96。
  • POD1和肽素<4.3 pmol/L预测AVD,敏感度0.82、特异度0.63、阴性预测值0.96。
  • 早期和肽素>22.9 pmol/L时排除AVD的敏感度95%、阴性预测值99%。

核心结论

  • 术后早期和肽素样本中,诊断AVD的最佳切点为<8.5 pmol/L,水平>22.9 pmol/L有助于排除AVD。
  • 解读和肽素结果需谨慎,因为术中接受糖皮质激素而无AVD的患者和肽素中位数较低。

研究设计与样本

  • 研究纳入2020年2月至2022年4月因垂体病变手术且无术前AVD的成人,术后早期(拔管后6小时内)和POD1(拔管后10-30小时)采血,用免疫荧光法测和肽素。
  • 共纳入192例患者(54.2%女性),中位年龄54.5岁(IQR 39.8-67.0岁)。

主要发现

  • 发生AVD(暂时或永久,n=22,11.5%)者中位和肽素低于未发生者:早期4.9 vs 18.7 pmol/L(p<0.001),POD1 3.4 vs 4.9 pmol/L(p<0.001)。
  • 暂时性与永久性AVD患者间和肽素无差异。
  • 颅咽管病变手术者AVD比例高于垂体腺瘤手术者(60.0% vs 8.8%,p<0.001),和肽素更低(早期4.3 vs 17.0 pmol/L,p<0.001;POD1 2.7 vs 4.9 pmol/L,p<0.001)。
  • 持续库欣病患者和肽素低于缓解者,但差异未达统计学显著(早期p=0.11,POD1 p=0.52)。
  • 和肽素不能预测抗利尿激素不适当分泌综合征的发生。

关键数值与推荐

  • 早期和肽素预测AVD最佳切点<8.5 pmol/L:敏感度0.70,特异度0.80,阳性预测值0.29,阴性预测值0.96。
  • POD1和肽素预测AVD最佳切点<4.3 pmol/L:敏感度0.82,特异度0.63,阳性预测值0.22,阴性预测值0.96。
  • 早期和肽素切点22.9 pmol/L时检测AVD敏感度95%,阴性预测值99%。

临床怎么用

  • 术后早期和肽素<8.5 pmol/L或POD1<4.3 pmol/L可用于预测AVD,阴性预测值均为0.96。
  • 早期和肽素>22.9 pmol/L有助于排除AVD,阴性预测值99%。
  • 解读和肽素结果需谨慎,术中接受糖皮质激素者和肽素中位数较低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Arginine vasopressin deficiency (AVD) following neurosurgical procedures for pituitary disorders is common and can delay discharge. Copeptin, a stable surrogate marker of arginine vasopressin, may predict postoperative AVD. The authors' aim was to assess the optimal postoperative sampling time and cut-point concentration of copeptin to predict the development of postsurgical AVD. METHODS: Adults without preexisting AVD who were undergoing surgery for a pituitary lesion between February 2020 and April 2022 were eligible for study inclusion. Two samples were drawn from each patient postoperatively to assess the copeptin concentration using an immunofluorescent assay. Samples were denoted as "early" (within 6 hours of extubation) or "postoperative day 1" (POD1; within 10-30 hours of extubation). Patients were evaluated for the development of AVD. RESULTS: One hundred ninety-two patients (54.2% female) with a median age of 54.5 years (IQR 39.8-67.0 years) were included in the study. The median copeptin concentration at both time points was significantly lower in those with AVD (transient or permanent; n = 22, 11.5%) than in those without (early: 4.9 vs 18.7 pmol/L, p < 0.001; POD1: 3.4 vs 4.9 pmol/L, p < 0.001) but did not differ in those who developed transient versus permanent AVD. The optimal copeptin cut point for the prediction of AVD was < 8.5 pmol/L for early samples (sensitivity 0.70, specificity 0.80, positive predictive value [PPV] 0.29, negative predictive value [NPV] 0.96) and < 4.3 pmol/L for POD1 samples (sensitivity 0.82, specificity 0.63, PPV 0.22, NPV 0.96). In early samples, a copeptin cutoff of 22.9 pmol/L increased the sensitivity for the detection of AVD to 95% with an NPV of 99%. The proportion of patients who had AVD was higher (60.0% vs 8.8%, p < 0.001) and the copeptin concentration lower (early: 4.3 vs 17.0 pmol/L, p < 0.001; POD1: 2.7 vs 4.9 pmol/L, p < 0.001) among those who had undergone surgery for a craniopharyngeal duct pathology versus a pituitary adenoma. Although copeptin was lower in patients with persistent Cushing's disease than in those in remission, the difference did not reach statistical significance (early p = 0.11, POD1 p = 0.52). Furthermore, the copeptin concentration could not predict the development of syndrome of inappropriate secretion of antidiuretic hormone. Patients without AVD who had received stress dose steroids intraoperatively had lower median early copeptin (11.7 vs 19.1 pmol/L, p = 0.027). CONCLUSIONS: In early postoperative copeptin samples, the optimal copeptin cut point for AVD diagnosis was < 8.5 pmol/L, and a level > 22.9 pmol/L had predicative utility in excluding AVD. Caution should be used when interpreting copeptin results, as patients administered glucocorticoids intraoperatively without AVD had lower median copeptin concentrations.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Donegan D, Bornhorst J, Van Gompel J, et al. Postsurgical utility of copeptin for the prediction of postoperative arginine vasopressin deficiency. J Neurosurg. 2023. PMID: 37948691. doi:10.3171/2023.8.JNS23418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。